During the past decade, St. Clair Nephrology Research conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 2 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 2 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St. Clair Nephrology Research" #1 sponsor was "Goldfinch Bio, Inc." with 3 trials, followed by "Regulus Therapeutics Inc." with 2 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored, "Complexa, Inc." with 1 trials sponsored and "Ironwood Pharmaceuticals, Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St. Clair Nephrology Research" #1 collaborator was "Medpace, Inc." with 2 trials as a collaborator, "Arkana Labs" with 1 trials as a collaborator, "Iqvia Pty Ltd" with 1 trials as a collaborator, "Kidney Research Network, formerly NephCure Accelerating Cures Institute" with 1 trials as a collaborator and "MicroConstants" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "St. Clair Nephrology Research" are "Diabetic Nephropathies" (2 trials), "Glomerulonephritis" (2 trials), "Glomerulosclerosis, Focal Segmental" (2 trials), "Kidney Diseases" (2 trials) and "Nephritis" (2 trials). Many other conditions were trialed in "St. Clair Nephrology Research" in a lesser frequency.

Most popular intervention types in "St. Clair Nephrology Research" are "Drug" (7 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "GFB-887" (2 trials), "Belatacept" (1 trials), "CXA-10" (1 trials) and "Cyclosporine" (1 trials). Other intervention names were less common.

The vast majority of trials in "St. Clair Nephrology Research" are 9 trials for "All" genders.

Currently, there are NaN active trials in "St. Clair Nephrology Research". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in St. Clair Nephrology Research, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in St. Clair Nephrology Research, 2 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".